每周股票复盘：华润双鹤（600062）获准发行30亿公司债

Core Viewpoint - China Resources Double Crane (华润双鹤) has received approval from the China Securities Regulatory Commission (CSRC) to publicly issue corporate bonds totaling up to 3 billion yuan, which will enhance its financial flexibility and support future growth initiatives [1][3]. Company Announcements - The company reported a stock price increase, closing at 18.76 yuan, up 0.21% from the previous week, with a market capitalization of 19.487 billion yuan, ranking 25th in the chemical pharmaceutical sector [1]. - The company’s subsidiary, Xi'an Jingxi Double Crane Pharmaceutical Co., Ltd., has obtained a drug registration certificate for Sodium Acetate Injection, which is classified as a Class 3 chemical drug and is considered to have passed the consistency evaluation [2][3]. - The new product, Sodium Acetate Injection, is intended for extracellular fluid supplementation and correction of metabolic acidosis, which will enhance the company's product line and market competitiveness [2].